| Tag | Content |
|---|
EnhancerAtlas ID | HS182-01092 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr1:87258370-87259420 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr1:87258743-87258758 | TGTCCTATTGACCTC | - | 6.79 | | POU4F2 | MA0683.1 | chr1:87258377-87258393 | CTAATTTACTATGCAC | - | 6.07 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_00777 | chr1:87252469-87262003 | Adipose_Nuclei |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I086792 | chr1 | 87257746 | 87261108 |
|
Enhancer Sequence | CTAATGTCTA ATTTACTATG CACCACAAAT AGAAATAAAC TCATTGCATA TTTTTCTCTT 60
CTTTATATTT CTGGTATTGC CCTCAGCAGT TAGTAACTAC AGTTCTAGAA ATCTGTTTCC 120
ACCCTCATAA TACATCTCAG CAGCTGCCAG TGGATGGAGG CTACCCAAGC CCCATGGCAA 180
CTGTTCAAAC AGCTGAGGGA AGCTTTAGGG TGGAGAGTGG CGCCAGGCCA GAGCCAGTGA 240
GAGCCGCAGG CAGGTAGAGT GGCACGCACC TGCCACAGGA CACCTGGCTG ACACACAGCC 300
CTGGGTACAG GAAGGGAGGA CTTAACACAC ACAAAAACTC ATCTTTGATG GCAGTTCAGC 360
TCCTTCTCTC TCCTGTCCTA TTGACCTCTT AGACTTTGTA ATCTTTCAGG AGCCAGTTGT 420
ATTTATCTGT CTGCCATGGC TGAGACTTGC TCATAGACAA GGGCTGGTTA GCAAGCCTGT 480
CCCTTTGTTC CTAAGAGGCA GAGAAAGAAT CTTTGACCCT GATTTCTAAG CACAGTAAAC 540
AAAGGCCTTC TTGGCTGCCA GTAAGCTCAA AGTGTTCATT AAGCAAGAAG TTTTCTGGCC 600
AGTGGTTGAA ATGACATCAT GCTTCCTCCT GGAATCCAAC TAGAGATAAA AATCAGGTCA 660
TTCAATTTAC AAAGAGAGAA TGCTCCCTTC TGCTGCCAGC ATTCAGGGGC TGCTGGCTTT 720
CAAAGAGATC AAGGGCAAGA AGAGCCTATT TGAACCCAGG CTTTGAGATG GTCTCTGAAA 780
CTACCTCCAC TTAATTCCTC ATAATATGCA AAGAAATTCC ACCCCAAATG TCCTCACGTC 840
AGAGAGCAGC TTATCTTTGC TGATTTTTCA AACTGAGTGT TTAACCAGAT GTGGCAGTGA 900
GGAGGTAGGT CTTATTAGCT GATAATGGAA TAGTCTTTCA GGCCCTCTAA ATACAAGAGG 960
ATGGAAGAAA TGGATTATCT TCATCTTTTG ACACCATTGA TCAAAATTTG AAGTGGGGAA 1020
GAAAAAAGTA TTGTGGTCTT AAAGATGTCC 1050
|
